BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

DiagnoCure Inc. 

2050 Boulevard, Rene-Levesque Ouest, 6th Floor

Sainte-Foy  Quebec  G1V 2K8  Canada
Phone: 418-527-6100 Fax: 418-527-0240


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals

Collaborations

Gen-Probe Incorporated (Acquired by Hologic)  In November 2003, Gen-Probe signed a license and collaboration agreement with DiagnoCure under which the companies are developing, and Gen-Probe will market, an innovative urine test to detect a new, highly specific genetic marker for prostate cancer called PCA3.





 Company News
DiagnoCure (CUR) Announces Presentation on Previstage GCC at the 2013 American Society of Clinical Oncology Annual Meeting 5/16/2013 7:39:14 AM    More...
DiagnoCure (CUR) Directors Re-Elected by Shareholders at Annual and Special Meeting of Shareholders 4/30/2013 10:22:53 AM    More...
DiagnoCure (CUR)'s Update Presentation During the Annual and Special Meeting of Shareholders 4/29/2013 10:57:10 AM    More...
DiagnoCure (CUR) Urges Shareholders to Vote Today to Protect Your Investment From Dissident Minority Shareholders - What is the Dissidents' Plan? Disruption to Newly-Formed and Highly-Qualified Board may Jeopardize Company's Future 4/22/2013 10:47:29 AM    More...
DiagnoCure (CUR)'s Adoption of an Advance Notice Policy 4/9/2013 9:18:07 AM    More...
DiagnoCure (CUR) Begins Trading on OTCQX® 4/2/2013 9:36:31 AM    More...
DiagnoCure (CUR) Joins the OTCQX Marketplace and S&P Corporation Records Listing 4/2/2013 9:34:47 AM    More...
DiagnoCure (CUR) Announces First Quarter 2013 Results 3/12/2013 6:34:09 AM    More...
DiagnoCure (CUR) to Host Q1 2013 Earnings Conference Call and Webcast 2/28/2013 10:26:17 AM    More...
DiagnoCure (CUR) Announces Fourth Quarter 2012 and Year-End Results 1/14/2013 6:13:06 AM    More...
12345678910...